Primary Sclerosing Cholangitis (PSC) Clinical Trial
Official title:
P.R.O.G.R.E.S.S.: PSC Resource Of Genetic Risk, Environment and Synergy Studies.
Primary Sclerosing Cholangitis (PSC) is a progressive liver disorder of unknown cause. Current evidence suggests that genes, the genetic material we inherit from our parents, in combination with environmental factors, likely play an important role in the development of PSC. This study is being done to investigate whether genes make people more likely to develop PSC. Discovery of these genes will help us to better understand how PSC developes and subsequently, to apply new approaches for its prevention, diagnosis and treatment.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05082779 -
Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CS0159
|
Phase 1 | |
| Completed |
NCT06037577 -
Subcutaneous Doses of CM-101 as a Treatment for Medical Conditions Involving Inflammatory and Fibrotic Mechanisms in Healthy Male Subjects
|
Phase 1 | |
| Completed |
NCT01672853 -
Simtuzumab (GS-6624) in the Prevention of Progression of Liver Fibrosis in Adults With Primary Sclerosing Cholangitis (PSC)
|
Phase 2 | |
| Completed |
NCT02061540 -
Open Label Study to Evaluate Safety and Efficacy of LUM001 in Patients With Primary Sclerosing Cholangitis
|
Phase 2 | |
| Completed |
NCT01819766 -
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
|
N/A | |
| Completed |
NCT02808312 -
Pharmacokinetics and Pharmacodynamics of Cilofexor in Adults With Normal and Impaired Hepatic Function
|
Phase 1 | |
| Completed |
NCT03333928 -
A POC and Dose-Ranging Study of HTD1801 in PSC Patients
|
Phase 2 | |
| Completed |
NCT02177136 -
Obeticholic Acid (OCA) in Primary Sclerosing Cholangitis (PSC)
|
Phase 2 | |
| Completed |
NCT03766035 -
Cholangioscopy in Primary Sclerosing Cholangitis (PSC)
|
||
| Completed |
NCT01695174 -
A Pilot Study of Xifaxan to Treat Patients With PSC
|
Phase 1 | |
| Recruiting |
NCT06026865 -
S-adenosylmethionine (SAMe) in Patients With Primary Sclerosing Cholangitis (PSC)
|
N/A |